Background The disease burden from interstitial lung diseases (ILDs) is thought to be increasing globally, but there is a ...
Introduction Most research on idiopathic pulmonary fibrosis (IPF) has focused on the interplay among fibroblasts, the immune system and epithelial cells. There is growing evidence that microvascular ...
1 NHS Centre for Smoking Cessation and Training (NCSCT), University College London, London, UK 2 Cancer Research UK Health Behaviour Research Centre, University College London, London, UK Background ...
Background Cystic fibrosis (CF) lung disease is defined by large numbers of neutrophils and associated damaging products in the airway. Delayed neutrophil apoptosis is described in CF although it is ...
5 George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah, USA Correspondence to Dr Shamus R Carr, Division of Thoracic Surgery, University of Maryland School of Medicine, ...
Background Ambulatory management of primary spontaneous pneumothorax has been shown to reduce initial hospitalisation, but at the expense of increase adverse events. As a result, questions remain ...
Department of Epidemiology and Public Health, University College London, London, UK Dr M Thomas, Department of General Practice and Primary Care, University of Aberdeen, Foresterhill Health Centre, ...
Correspondence to Professor Anita K Simonds, NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust, London SW3 6NP, UK; A.Simonds{at}rbht.nhs.uk Loss of motor ...
1 Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK 2 Division of Therapeutics and Molecular Medicine, University of Nottingham, Nottingham, UK Correspondence to Dr ...
Background The aetiology of lung cancer among individuals who never smoked remains elusive, despite 15% of lung cancer cases in men and 53% in women worldwide being unrelated to smoking. Epigenetic ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
Background Disease modifying therapies for progressive fibrotic interstitial lung diseases (F-ILDs) slow physiological decline but have not consistently shown to improve patient-reported symptoms or ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results